What is the recommended acute management for a patient presenting with an acute ischemic stroke?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 21, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Acute Ischemic Stroke Management

For acute ischemic stroke, immediately administer IV alteplase 0.9 mg/kg (maximum 90 mg) within 4.5 hours of symptom onset, with 10% as a bolus over 1 minute and the remainder over 60 minutes, while simultaneously evaluating for endovascular thrombectomy in large vessel occlusions 1.

Time-Critical Reperfusion Strategy

The cornerstone of acute management is rapid reperfusion through two complementary pathways:

Intravenous Thrombolysis

  • Alteplase remains the standard thrombolytic with high-quality evidence supporting its use within 4.5 hours 1, 2
  • Tenecteplase is emerging as an alternative, though alteplase has more established evidence 3, 2
  • Do not delay treatment to pursue additional diagnostic studies beyond essential non-contrast CT to exclude hemorrhage 1
  • For wake-up strokes (last known normal >4.5 hours ago), use MRI DWI-FLAIR mismatch to identify candidates for thrombolysis 2

Endovascular Thrombectomy

  • Standard of care for large vessel occlusions in both anterior and posterior circulation 3
  • Evaluate immediately and simultaneously with thrombolysis consideration—do not delay one for the other
  • Treatment windows have expanded beyond traditional timeframes based on advanced imaging selection 3

Critical Monitoring Protocol

After alteplase administration, follow this strict monitoring schedule 1:

  • First 2 hours: BP and neurological assessments every 15 minutes
  • Next 6 hours: Every 30 minutes
  • Until 24 hours: Hourly assessments
  • Target BP: Maintain SBP ≤180 mmHg and DBP ≤105 mmHg
  • Admit to intensive care or dedicated stroke unit 1

Management of Complications

If Symptomatic Intracranial Hemorrhage Develops 1:

  1. Stop alteplase immediately
  2. Obtain emergent non-contrast head CT
  3. Send CBC, PT/INR, aPTT, fibrinogen, type and cross-match
  4. Administer cryoprecipitate 10 units over 10-30 minutes (repeat if fibrinogen <200 mg/dL)
  5. Consider tranexamic acid 1000 mg IV over 10 minutes OR ε-aminocaproic acid 4-5 g over 1 hour
  6. Consult hematology and neurosurgery emergently

Delay Invasive Procedures 1:

  • Nasogastric tubes
  • Indwelling bladder catheters
  • Intra-arterial pressure catheters
  • Only place if patient cannot be safely managed without them

Post-Thrombolysis Care

  • Obtain follow-up CT or MRI at 24 hours before starting any anticoagulants or antiplatelet agents 1
  • Manage blood pressure, glucose, temperature, and oxygenation to optimize cerebral protection 4
  • Screen for dysphagia before oral intake 5
  • Begin early secondary prevention planning 4

Common Pitfalls to Avoid

The 2018 AHA/ASA guidelines 1 explicitly warn against delaying treatment for additional diagnostic workup beyond essential imaging. The most recent 2026 updates 5 reinforce this time-critical approach while expanding eligibility criteria and introducing pediatric considerations. The key error is hesitation—stroke is a time-dependent emergency where "time is brain." Every 15-minute delay in treatment reduces the likelihood of good functional outcome.

The European Stroke Organisation guidelines 2 provide concordant high-quality evidence supporting this aggressive early intervention approach, particularly emphasizing appropriate patient selection through rapid clinical and imaging assessment rather than exhaustive testing that delays treatment.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.